SCHEMBL28873192

SCHEMBL28873192

CC(C)(C)OC(=O)CC(N)CCCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 6/20 0.49
ALDH1A1 P00352 1/20 0.45
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30036241 1.00 ENPEP (0.49) ENPEPALDH1A1HDAC3HDAC1HDAC2
SCHEMBL28873191 0.90 HDAC8 (0.40) ENPEPALDH1A1HDAC3HDAC1HDAC2
SCHEMBL15630694 0.83 CTSK (0.43) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL27936273 0.83 CTSK (0.43) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL20223064 0.83 CTSK (0.43) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL7074842 0.81 S1PR2 (0.41) ALDH1A1GRIK1SLC1A2SLC1A1GRIK2
SCHEMBL27517907 0.81 S1PR2 (0.41) ALDH1A1GRIK1SLC1A2SLC1A1GRIK2
SCHEMBL7824510 0.80 CYP2D6 (0.40) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL10825310 0.80 S1PR2 (0.44) ALDH1A1GRIK1SLC1A2SLC1A1GRIK2
SCHEMBL31301962 0.80 CYP2D6 (0.44) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110177780-B Pyrimidine compounds containing acidic groups 阿普罗斯治疗公司 2022-11-01 CN disclosed